A 2021 clinical study of chronic knee pain patients found 87.5% reported significant relief after BPC-157, lasting 6 months to a year
that compliance and monitoring are better in patients who receive this form of therapy because they have frequent contact with health care providers, whereas proponents of oral therapy maintain that compliance will be improved in patients who receive oral therapy because of convenience, comfort, and decreased expense
All doses through 10 mg/week fit in a single 1 mL syringe at this concentration
Signal Amplification: Activated receptors trigger G-protein coupling, adenylyl cyclase activation, and dramatic increases in intracellular cAMP (often 10-100 fold elevation)
Some people feel better in 2472 hours
Were the Manufacturer: Because we produce in-house, we control purity, potency, and compliance instead of reselling from anonymous overseas labs